New Zealand Ibogaine Study Enrolls Fifth Subject

On November 9, 2012, the fifth participant was enrolled in our ongoing observational study of ibogaine treatment for addiction in New Zealand. All participants had been receiving methadone treatment for opiate addiction and are being treated for methadone dependence at independent ibogaine clinics in New Zealand. The study was approved by the IRB on February 22, 2012, and lead investigator Dr. Geoff Noller, Ph.D., began enrollment shortly thereafter. This study is the second in our international series of observational studies of the safety and long-term effectiveness of ibogaine treatment for addiction, building on our completed study in Mexico.